---
schema_version: "secwatch.filing_event.v1"
accession: "0001516513-25-000092"
form_type: "8-K"
ticker: "DOCS"
cik: "0001516513"
company_name: "Doximity, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:29:01.850610+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Doximity Q1 revenue $145.9M (+15%), adj. EBITDA $79.8M (+21%), raises FY guidance

## Summary
- Revenue $145.9M (+15% YoY); net income $53.3M (36.5% margin); non-GAAP EPS $0.36.
- Adjusted EBITDA $79.8M (+21% YoY), margin 54.7%; operating cash flow $62.1M (+51%).
- FY2026 guidance raised: revenue $628M-$636M, adj. EBITDA $341M-$349M.
- AI suite fastest growing, up 5x YoY; over 630K prescribers used workflow tools.
- Acquired Pathway Medical (details in separate release).

## SEC filing metadata
- accession: 0001516513-25-000092
- form_type: 8-K
- ticker: DOCS
- cik: 0001516513
- company_name: Doximity, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516513/000151651325000092/0001516513-25-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516513/000151651325000092/docs-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516513-25-000092
- JSON: https://secwatch.observer/filing/0001516513-25-000092.json
- Plain text: https://secwatch.observer/filing/0001516513-25-000092.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.